Novartis Investigative Site
Bari, Apulia 70126
0 studies enrolling now · 5 studies all time
What they study most
IgA Nephropathy, Immunoglobulin A Nephropathy, Leukaemia, Lymphocytic, Chronic, Neoplasms, Breast, Neoplasms, Gastrointestinal Tract, Ovarian Cancer
Studies at this site
- A Study of Zigakibart in Adults With IgA Nephropathy — Running, not enrolling
- LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib — Completed
- Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
- Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia — Stopped early
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING